New Hope for Chronic Kidney Disease Patients After the JUPITER Trial: Myth or Reality?

According to their results, rosuvastatin reduces first cardiovascular events and all-cause mortality among men and women with low-density lipoprotein cholesterol

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2010-08, Vol.56 (6), p.529-529
Hauptverfasser:	Kassimatis, Theodoros I., Goldsmith, David J.A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Creatinine - blood Diabetes Disease prevention Disease Progression Drug therapy Female Glomerular Filtration Rate Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Kidney diseases Kidney Failure, Chronic - blood Kidney Failure, Chronic - complications Kidney Failure, Chronic - physiopathology Male Middle Aged Mortality Randomized Controlled Trials as Topic Statins Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	According to their results, rosuvastatin reduces first cardiovascular events and all-cause mortality among men and women with low-density lipoprotein cholesterol
ISSN:	0735-1097 1558-3597
DOI:	10.1016/j.jacc.2010.04.027